SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferation

BACKGROUND: SPARC is a matricellular glycoprotein with growth-inhibitory and antiangiogenic activity in some cell types. The study of this protein in hematopoietic malignancies led to conflicting reports about its role as a tumor suppressor or promoter, depending on its different functions in the tu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Giallongo, Cesarina, La Cava, Piera, Tibullo, Daniele, Barbagallo, Ignazio, Parrinello, Nunziatina, Cupri, Alessandra, Stagno, Fabio, Consoli, Carla, Chiarenza, Annalisa, Palumbo, Giuseppe A, Di Raimondo, Francesco
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2013
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3570354/
https://ncbi.nlm.nih.gov/pubmed/23383963
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-60
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados